Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

Dry cough typically indicates COVID-19 compared with the flu. RSV, or respiratory syncytial virus, usually causes mild symptoms akin to cold that go away on their own. But for babies, some young ...

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 ...

Jan 29 (Reuters) - Two European regulators said on Wednesday they were tracking variants of the bird flu virus due to the threat of the pathogen adapting to spread between humans and triggering ...

Influenza virus is an infectious agent belonging to the virus family Orthomyxoviridae that causes a respiratory tract infection (influenza or 'flu') in vertebrates. There are three main species ...

While RSV isn’t any more virulent than the cold, flu or COVID, the same precautions are recommended in order to control its ...